Dosierungsfragen bei fibrinolytischer Langzeittherapie mit Streptokinase
暂无分享,去创建一个
[1] H. Poliwoda,et al. Fibrinolytische Therapie chronischer Phlebothrombosen , 1971 .
[2] J. Hirsh,et al. Evaluation of a standard dosage schedule with streptokinase. , 1970, Blood.
[3] I. Nilsson,et al. Plasmin, plasmin inhibitors, and degradation products of fibrinogen in human serum during and after intravenous infusion of streptokinase. , 1969, Journal of clinical pathology.
[4] A. Amery,et al. Recent progress in thrombolytic therapy. , 1969, Journal of clinical pathology.
[5] E. Zeitler,et al. Beseitigung alter Arterienverschlüsse durch intravenöse Streptokinase-Infusion , 1968 .
[6] Deutsche Medizinische,et al. Thrombolytische Therapie bei akuten Gefäßverschlüssen , 1967 .
[7] A. Amery,et al. Thrombolytic Therapy with Streptokinase Using a Standard Dosage Scheme , 1966, British medical journal.
[8] A. Johnson,et al. The lysis of artificially induced intravascular clots in man by intravenous infusions of streptokinase. , 1959, The Journal of clinical investigation.
[9] G. Nylander,et al. Thrombolytic effect of streptokinase as evaluated by phlebography of deep venous thrombi of the leg. , 1970, Acta chirurgica Scandinavica.
[10] R. Schmutzler. Thrombolytic treatment of acute peripheral arterial and venous occlusions. , 1968, Angiologica.
[11] A. Amery,et al. PRACTICAL METHOD FOR THROMBOLYTIC THERAPY WITH STREPTOKINASE. MAINTENANCE OF NEARLY COMPLETE PLASMINOGEN DEPLETION ASSOCIATED WITH HIGH CIRCULATING ACTIVATOR ACTIVITY. , 1964, British medical journal.